Tag: UH Hospitals

Clinical Trial Shows Injectable Weight Loss Drug Directly Reduces Abdominal Fat

Findings could potentially widen use for overweight adults who are high risk for heart disease   CLEVELAND – A clinical trial led by Dr. Ian Neeland with University Hospitals Harrington Heart & Vascular Institute could have implications for overweight and obese adults who may benefit from reducing intra-abdominal fat. The […]